Guangzhou Regen Therapeutics Raises RMB 100 Million in Pre-Series A Financing
CompanyDeals

Guangzhou Regenverse Therapeutics Raises RMB 100 Million in Pre-Series A Financing

Novo Nordisk Reports 18% YOY Revenue Growth in Q1 2025
Company

Novo Nordisk Reports 18% YOY Revenue Growth in Q1 2025

Sino Biopharmaceutical and JD Healthcare Forge Comprehensive Strategic Partnership
CompanyDeals

Sino Biopharmaceutical and JD Healthcare Forge Comprehensive Strategic Partnership

Adicon Holdings Acquires Suzhou Youqin Medical Laboratory and Yuande Weikang
CompanyDeals

Adicon Holdings Acquires Suzhou Youqin Medical Laboratory and Yuande Weikang

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies
CompanyDeals

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies

BeiGene's Q1 2025 Revenues Soar 49% YOY, Driven by Brukinsa Global Sales
Company

BeiGene’s Q1 2025 Revenues Soar 49% YOY, Driven by Brukinsa Global Sales

European Commission Approves J&J's Tremfya for Crohn's Disease Treatment
CompanyDrug

European Commission Approves J&J’s Tremfya for Crohn’s Disease Treatment

Amgen Reports 9% Revenue Growth in Q1 2025, Driven by Double-Digit Product Sales
Company

Amgen Reports 9% Revenue Growth in Q1 2025, Driven by Double-Digit Product Sales

AstraZeneca and Daiichi Sankyo Announce Positive DESTINY-Breast11 Trial Results for Enhertu
CompanyDrug

AstraZeneca and Daiichi Sankyo Announce Positive DESTINY-Breast11 Trial Results for Enhertu

Siemens Healthineers Reports Q2 2025 Revenue Up 6.8% to EUR 5.909 Billion
Company

Siemens Healthineers Reports Q2 2025 Revenue Up 6.8% to EUR 5.909 Billion

Grand Pharma Receives NMPA Review for Phase III Trial of TLX591 in Prostate Cancer
CompanyDrug

Grand Pharma Receives NMPA Review for Phase III Trial of TLX591 in Prostate Cancer

Biogen Reports 8% YOY Sales Growth in Q1 2025, Driven by Rare Disease Therapies
Company

Biogen Reports 8% YOY Sales Growth in Q1 2025, Driven by Rare Disease Therapies